Regulations
GLOBAL
»
ICH GCP (De)
ICH GCP (En)
ICH GCP (Es)
ICH GCP (Fr)
ICH GCP (It)
ICH GCP (Pt)
ICH GCP (Ru)
USA (FDA)
UK (MHRA)
AUSTRALIA (NHMRC)
JAPAN (PMDA)
EU (EMA)
CRO List
Clinical Trials
US Clinical Trials Registry
EU Clinical Trials Registry
Pharmaceutical Companies
Clinical Research Labs
Service Companies
Clinical Research Events
Publications
Researchers
Jobs
Publications
News
ICH GCP
US Clinical Trials Registry
Search trials
Condition or disease:
Intervention/Treatment:
Sponsor:
Location:
Only recruiting and not yet recruiting studies
Search clinical trials for: 18F-DCFBC
Total 0 results
Nothing found
Sponsors and Collaborators
Heilongjiang Zhenbaodao Pharmaceutical Co., Ltd.
Neurophth Therapeutics Inc
Jiande Branch, Second Affiliated Hospital, School of Medicine, Zhejiang University
Eurofins Genoma
RMIT University, Melbourne, Australia
Aptis Medical
Hospital Durand, Argentina
Mª Victoria Maestre Sanchez
Korean Society of Spine Surgery
Nacuity Pharmaceuticals, Inc.
Kupfer, David J., M.D.
ASST Cremona, Cremona
Hospital ASEPEYO Sant Cugat
Apollo Neuroscience, Inc.
GFI
Principal Investigator Mohanad Omar Ahmed, Msc Pharmacy Practice Department- Horus University
iCAD
Alma Lasers Inc.
Agency for Science, Technology and Research
Everett Meyer
View Full List
Medical Conditions
Gastric Cancer Stage IIIB-IIIC
The Strength Properties of the Aorta in Vitro
Disorder of Fluid Balance
Metachronous Adenoma
Rheumatoid Arthritis(RA)
Splenic Trauma
Fever
Corneal Cross-Linking
Chronic Constipation Symptoms
Recurrent Clear Cell Sarcoma of Soft Tissue
STAGE IIIA/B NSCLC / INOPERABLE LUNG CANCER
24 Hours Esophageal PH and Multichannel Intraluminal Impedance Testing
Treatment Decisions
Dienogest
Immune-Mediated Inflammatory Disease
Luteal Phase Support
RISS Stage III Plasma Cell Myeloma
T-LGL Leukemia
Scleredema
Major Liver Surgery
View Full List
Drug Interventions
Intravenous deferiprone
Capecitabine/cisplatin
TPN-101
Midazolam
Desvenlafaxine
Fospropofol disodium, propofol
OnabotulinumtoxinA
Intravenous Formulation of PD-0332991
Camptosar
THC
Oxycodone/acetaminophen 5/325 mg
Anticholinergic
Capecitabine and IMRT (if randomized to this arm)
Standard of care (SOC) for COVID-19
MLN2480
Olopatadine
Letrozole
PD-1/PD-L1 inhibitor
GLPG1837 multiple ascending doses
RDX227675
View Full List
CROs by country
Contract Research Organizations in Albania
Contract Research Organizations in Armenia
Contract Research Organizations in Chile
Contract Research Organizations in Finland
Contract Research Organizations in Gabon
Contract Research Organizations in Japan
Contract Research Organizations in Kenya
Contract Research Organizations in Kosovo
Contract Research Organizations in Macedonia
Contract Research Organizations in Mauritania
Contract Research Organizations in Mozambique
Contract Research Organizations in Saint Lucia
Contract Research Organizations in Thailand
CRO list by country
CROs in Iran
Farzan Clinical Research
SGS
All CROs in Iran
3
✕
GOOD CLINICAL PRACTICE NETWORK
Subscribe to receive notifications of regulatory updates and industry news!
Subscribe
GOOD CLINICAL PRACTICE NETWORK
Subscribe to receive notifications of regulatory updates and industry news!
Subscribe
Subscribe